{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1363667548347869568.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1007/s10384-014-0352-2"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s10384-014-0352-2.pdf"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/article/10.1007/s10384-014-0352-2/fulltext.html"}},{"identifier":{"@type":"URI","@value":"http://link.springer.com/content/pdf/10.1007/s10384-014-0352-2"}},{"identifier":{"@type":"PMID","@value":"27311268"}},{"identifier":{"@type":"PMID","@value":"25707353"}},{"identifier":{"@type":"NAID","@value":"210000165079"}}],"dc:title":[{"@value":"Diagnostic criteria for IgG4-related ophthalmic disease"}],"description":[{"notation":[{"@value":"Immunoglobulin G4 (IgG4)-related disease is a novel clinical entity characterized by infiltration of IgG4-immunopositive plasmacytes and elevated serum IgG4 concentration accompanied by enlargement of and masses in various organs, including the lacrimal gland, salivary gland, and pancreas. Recent studies have clarified that conditions previously diagnosed as Mikulicz disease as well as various types of lymphoplasmacytic infiltrative disorders of the ocular adnexa are consistent with a diagnosis of IgG4-related disease. Against this background, the diagnostic criteria for IgG4-related ophthalmic disease have recently been established, based on both the clinical and the histopathologic features of the ocular lesions. This article reviews these new criteria with reference to the comprehensive diagnostic criteria for IgG4-related disease for all systemic conditions reported in 2012."}]}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1581980232945013635","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000415154267"}],"foaf:name":[{"@value":"Hiroshi Goto"}]},{"@id":"https://cir.nii.ac.jp/crid/1581980232945013632","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000415154269"}],"foaf:name":[{"@value":"Masahiro Takahira"}]},{"@id":"https://cir.nii.ac.jp/crid/1581980232945013634","@type":"Researcher","personIdentifier":[{"@type":"NRID","@value":"9000415154270"}],"foaf:name":[{"@value":"Atsushi Azumi"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"16132246"},{"@type":"EISSN","@value":"16132246"}],"prism:publicationName":[{"@value":"Japanese Journal of Ophthalmology"}],"dc:publisher":[{"@value":"Springer Science and Business Media LLC"}],"prism:publicationDate":"2014-11-14","prism:volume":"59","prism:number":"1","prism:startingPage":"1","prism:endingPage":"7"},"reviewed":"false","dc:rights":["http://www.springer.com/tdm"],"url":[{"@id":"http://link.springer.com/content/pdf/10.1007/s10384-014-0352-2.pdf"},{"@id":"http://link.springer.com/article/10.1007/s10384-014-0352-2/fulltext.html"},{"@id":"http://link.springer.com/content/pdf/10.1007/s10384-014-0352-2"}],"createdAt":"2014-11-14","modifiedAt":"2019-05-29","foaf:topic":[{"@id":"https://cir.nii.ac.jp/all?q=Lacrimal%20Apparatus%20Diseases","dc:title":"Lacrimal Apparatus Diseases"},{"@id":"https://cir.nii.ac.jp/all?q=Eye%20Diseases","dc:title":"Eye Diseases"},{"@id":"https://cir.nii.ac.jp/all?q=Orbital%20Pseudotumor","dc:title":"Orbital Pseudotumor"},{"@id":"https://cir.nii.ac.jp/all?q=Immunoglobulin%20G","dc:title":"Immunoglobulin G"},{"@id":"https://cir.nii.ac.jp/all?q=Plasma%20Cells","dc:title":"Plasma Cells"},{"@id":"https://cir.nii.ac.jp/all?q=Humans","dc:title":"Humans"},{"@id":"https://cir.nii.ac.jp/all?q=Mikulicz'%20Disease","dc:title":"Mikulicz' Disease"}],"relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1050001335983875072","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"Clinical aspects of IgG4-related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders"},{"@value":"Clinical aspects of IgG4‐related orbital inflammation in a case series of ocular adnexal lymphoproliferative disorders"}]},{"@id":"https://cir.nii.ac.jp/crid/1050569612355133312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Upregulated Expression of Activation-Induced Cytidine Deaminase in Ocular Adnexal Marginal Zone Lymphoma with IgG4-Positive Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1050850247229020544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Association of serum levels of fibrosis-related biomarkers with disease activity in patients with IgG4-related disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360002217335715200","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current approach to the diagnosis of IgG4-related disease – Combination of comprehensive diagnostic and organ-specific criteria"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142571330048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The 2020 revised comprehensive diagnostic (RCD) criteria for IgG4-RD"}]},{"@id":"https://cir.nii.ac.jp/crid/1360009142647767808","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Comprehensive Gene Analysis of IgG4-Related Ophthalmic Disease Using RNA Sequencing"}]},{"@id":"https://cir.nii.ac.jp/crid/1360017282192700928","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Lacrimal Gland and Orbital Lesions in Lat<sup>Y136F</sup> Knock-in Mice, a Model for Human IgG4-Related Ophthalmic Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360021390559675136","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Pediatric IgG4-related disease: a descriptive review"}]},{"@id":"https://cir.nii.ac.jp/crid/1360025430194020224","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Factors related to elevated serum immunoglobulin G4 (IgG4) levels in a Japanese general population"}]},{"@id":"https://cir.nii.ac.jp/crid/1360283693476249472","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Interleukin-21 contributes to germinal centre formation and immunoglobulin G4 production in IgG4-related dacryoadenitis and sialoadenitis, so-called Mikulicz's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285705356903168","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Current Concept of IgG4-Related Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285706926592384","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Immunoglobulin G4-related dacyroadenitis presenting as bilateral chorioretinal folds from severely enlarged lacrimal glands"}]},{"@id":"https://cir.nii.ac.jp/crid/1360285714193333376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Validation of the comprehensive diagnostic criteria for IgG4-related disease in a SMART registry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617548286336","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Differential Tissue Metabolic Signatures in IgG4-Related Ophthalmic Disease and Orbital Mucosa-Associated Lymphoid Tissue Lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617556592000","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Involvement of two or more sets of lacrimal glands and/or major salivary glands is related to greater systemic disease activity due to multi-organ involvement in IgG4-related dacryoadenitis/sialadenitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360290617556661376","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Positive disease-specific autoantibodies have limited clinical significance in diagnosing IgG4-related disease in daily clinical practice"}]},{"@id":"https://cir.nii.ac.jp/crid/1360294643826303872","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Cases with IgG4-related ophthalmic disease with mass lesions surrounding the optic nerve"}]},{"@id":"https://cir.nii.ac.jp/crid/1360306906073923840","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical profile of IgG4-related disease in Japan based on the rare disease data registry"}]},{"@id":"https://cir.nii.ac.jp/crid/1360565165302344192","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Comprehensive diagnostic criteria for IgG4-related disease (IgG4-RD), 2011"}]},{"@id":"https://cir.nii.ac.jp/crid/1360567181214925952","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Gastrointestinal manifestation of immunoglobulin G4-related disease: clarification through a multicenter survey"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092525308544","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Identification of Markers Predicting Clinical Course in Patients with IgG4-Related Ophthalmic Disease by Unbiased Clustering Analysis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360572092640525312","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Distinctive Tissue and Serum MicroRNA Profile of IgG4-Related Ophthalmic Disease and MALT Lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094067871360","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"High prevalence of IgG4-related lymphoplasmacytic infiltrative disorder in 25 patients with orbital inflammation: a retrospective case series"}]},{"@id":"https://cir.nii.ac.jp/crid/1360574094903959936","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Serologic Factors in Early Relapse of IgG4-Related Orbital Inflammation After Steroid Treatment"}]},{"@id":"https://cir.nii.ac.jp/crid/1360576118835921152","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Autoimmune Epithelitis and Chronic Inflammation in Sjögren’s Syndrome-Related Dry Eye Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360582632751841792","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The 2023 revised diagnostic criteria for IgG4-related ophthalmic disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360583253614482176","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Evaluation of the specificity of trigeminal nerve enlargement in the diagnosis of IgG4-related ophthalmic disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360584339755835904","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"High serum IgA levels in patients with IgG4-related disease are associated with mild inflammation, sufficient disease-specific features, and favourable responses to treatments"}]},{"@id":"https://cir.nii.ac.jp/crid/1360586971785675392","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The 2023 revised diagnostic criteria for IgG4-related dacryoadenitis and sialadenitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1360846639367405696","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Recommendations for the nomenclature of IgG4‐related disease and its individual organ system manifestations"}]},{"@id":"https://cir.nii.ac.jp/crid/1360855570487805696","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"IgG4-Related Systemic Disease as a Cause of “Idiopathic” Orbital Inflammation, Including Orbital Myositis, and Trigeminal Nerve Involvement"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861288122780288","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"American College of Rheumatology and the European League Against Rheumatism classification criteria for IgG4-related disease: an update for radiologists"}]},{"@id":"https://cir.nii.ac.jp/crid/1360861704795952640","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Performance of classification and diagnostic criteria for IgG4-related disease and comparison of patients with and without IgG4-related disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1360866217151896448","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Postoperative outcomes of biopsy versus debulking surgery for immunoglobulin G4-related ophthalmic disease: a retrospective comparative study"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137045703346944","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Clonal relationship between infiltrating immunoglobulin G4 (IgG4)-positive plasma cells in lacrimal glands and circulating IgG4-positive lymphocytes in Mikulicz's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361137046478124160","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Enlargement of the Infraorbital Nerve"}]},{"@id":"https://cir.nii.ac.jp/crid/1361418521416274944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinicopathological differential diagnosis of IgG4‐related disease: A historical overview and a proposal of the criteria for excluding mimickers of IgG4‐related disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1361694365681474048","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"IgG4-related pleural disease with aortitis and submandibular glands involvement successfully treated with corticosteroid: case-based review"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699993758023552","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ocular adnexal IgG4‐related disease: comparative analysis with mucosa‐associated lymphoid tissue lymphoma and other chronic inflammatory conditions"}]},{"@id":"https://cir.nii.ac.jp/crid/1361699994491938560","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"High Serum IgG4 Concentrations in Patients with Sclerosing Pancreatitis"}]},{"@id":"https://cir.nii.ac.jp/crid/1361975845933382784","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"The natural course of IgG4-related ophthalmic disease after debulking surgery: a single-centre retrospective study"}]},{"@id":"https://cir.nii.ac.jp/crid/1361981471458262784","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Orbital Inflammation With IgG4-Positive Plasma Cells"}]},{"@id":"https://cir.nii.ac.jp/crid/1362262943331860864","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ocular Adnexal Lymphoma Associated With IgG4+ Chronic Sclerosing Dacryoadenitis: A Previously Undescribed Complication of IgG4-related Sclerosing Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107369958521600","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ocular adnexal IgG4‐related disease has uniform clinicopathology"}]},{"@id":"https://cir.nii.ac.jp/crid/1363107370442119168","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Ocular Adnexal IgG4-Related Lymphoplasmacytic Infiltrative Disorder"}]},{"@id":"https://cir.nii.ac.jp/crid/1363670318329130496","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Location and frequency of lesions in patients with IgG4-related ophthalmic diseases"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795280779648","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"IgG4-related Diseases Including Mikulicz’s Disease and Sclerosing Pancreatitis: Diagnostic Insights"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795614233088","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Elevated IgG4 concentrations in serum of patients with Mikulicz's disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1363951795688328576","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"IgG4-producing marginal zone B-cell lymphoma"}]},{"@id":"https://cir.nii.ac.jp/crid/1364233269388090112","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Respiratory involvement in IgG4-related Mikulicz’s disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001204408348800","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"眼窩内腫瘍の識別と治療"},{"@language":"en","@value":"Differential Diagnosis and Pathogenesis for Orbital Tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205013442176","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"興味深い臨床像を呈した好酸球性肉芽腫性多発血管炎 (Eosinophilic granulomatosis with polyangiitis: EGPA) 症例"},{"@language":"en","@value":"Case of EGPA and Eosinophilic Chronic Rhinosinusitis Concomitant with IgG4 Related Disease"},{"@value":"症例報告 興味深い臨床像を呈した好酸球性肉芽腫性多発血管炎(Eosinophilic granulomatosis with polyangiitis : EGPA) 症例 : EGPA"},{"@language":"ja-Kana","@value":"ショウレイ ホウコク キョウミブカイ リンショウゾウ オ テイシタ コウサンキュウセイ ニクガシュセイ タハツ ケッカンエン(Eosinophilic granulomatosis with polyangiitis : EGPA) ショウレイ : EGPA"}]},{"@id":"https://cir.nii.ac.jp/crid/1390001205323822208","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"IgG4関連眼疾患の10年と今後の課題について"},{"@language":"en","@value":"The First Decade and Next Agendas of IgG4-related Ophthalmic Disease"},{"@language":"ja-Kana","@value":"IgG4 カンレンガン シッカン ノ 10ネン ト コンゴ ノ カダイ ニ ツイテ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390009640069710080","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Pathophysiology, Treatment and Diagnosis of IgG4-related Disease"},{"@language":"ja","@value":"IgG4関連疾患の病態および診断と治療"},{"@language":"ja-Kana","@value":"IgG4 カンレン シッカン ノ ビョウタイ オヨビ シンダン ト チリョウ"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679616005504","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Clinical Diagnostic Criteria for Autoimmune Pancreatitis 2011 (Proposal)"},{"@language":"ja","@value":"報告　自己免疫性膵炎臨床診断基準2011"},{"@value":"Clinical diagnostic criteria for autoimmune pancreatitis 2011."},{"@value":"Clinical Diagnostic for Autoimmune Pancreatitis 2011 (Proposal) (in Japanese with English abstract)"}]},{"@id":"https://cir.nii.ac.jp/crid/1390282679679900416","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Local Recurrence as Immunoglobulin G4 (IgG4)-Related Disease 10 Years after Radiotherapy to Ocular Adnexal Extranodal Marginal Zone B-Cell Lymphoma of Mucosa-Associated Lymphoid Tissue"}]},{"@id":"https://cir.nii.ac.jp/crid/1390292350991819264","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Series: Diagnosis at a Glance"},{"@language":"ja","@value":"「一目瞭然！目で診る症例」問題・解答"}]},{"@id":"https://cir.nii.ac.jp/crid/1390294750821626368","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Histological features of autoimmune pancreatitis and IgG4-related sclerosing cholangitis with a correlation with imaging findings"},{"@language":"ja","@value":"自己免疫性膵炎およびIgG4関連硬化性胆管炎の組織学的特徴と画像所見との関連性"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564227342498944","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Optic neuropathy from connected intra- and extraorbital lesions in IgG4-related disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564238027468416","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Longstanding IgG4-related Ophthalmic Disease Dramatically Improved after Steroid Therapy"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564238035651456","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"ja","@value":"VII．IgG4関連疾患"},{"@language":"en","@value":"VII. IgG4-related Disease"},{"@value":"IgG4関連疾患"},{"@language":"ja-Kana","@value":"IgG4 カンレン シッカン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390564238106707072","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"IgG4-related Ophthalmic Disease Treated with Sinus Surgery"},{"@language":"ja","@value":"副鼻腔手術を行ったIgG4関連眼疾患"}]},{"@id":"https://cir.nii.ac.jp/crid/1390568860340609792","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Follow-up with serum IgG4-monitoring in 8 patients with IgG4-related disease diagnosed by a lacrimal gland mass"}]},{"@id":"https://cir.nii.ac.jp/crid/1390573482953296512","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"The 2020 Revised Comprehensive Diagnostic Criteria for IgG4-Related Disease. The Research Program for Intractable Disease by the Ministry of Health, Labour and Welfare (MHLW) Japan"},{"@language":"ja","@value":"2020年　改訂　IgG4関連疾患包括診断基準―The 2020 Revised Comprehensive Diagnostic（RCD）Criteria for IgG4-RD ―厚生労働省難治性疾患等政策研究事業　IgG4関連疾患の診断基準並びに診療指針の確立を目指す研究班"}]},{"@id":"https://cir.nii.ac.jp/crid/1390579941286680704","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Current topics of IgG4-related ophthalmic disease"},{"@language":"ja","@value":"IgG4関連眼疾患の最新の知見"},{"@language":"ja-Kana","@value":"IgG4 カンレンガン シッカン ノ サイシン ノ チケン"}]},{"@id":"https://cir.nii.ac.jp/crid/1390579941286717824","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"New diagnostic criteria for IgG4-related disease―the 2020 revised comprehensive diagnostic（RCD）criteria for IgG4-RD and the 2019 ACR／EULAR classification criteria for IgG4-related disease"},{"@language":"ja","@value":"新たなIgG4関連疾患診断基準―2020改訂IgG4関連疾患包括診断基準とThe 2019 ACR／EULAR classification criteria for IgG4-related disease"},{"@language":"ja-Kana","@value":"アラタ ナ IgG4 カンレン シッカン シンダン キジュン : 2020 カイテイ IgG4 カンレン シッカン ホウカツ シンダン キジュン ト The 2019 ACR/EULAR classification criteria for IgG4-related disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390583093132025728","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Validation of the Diagnostic Criteria for IgG4-Related Periaortitis/Periarteritis and Retroperitoneal Fibrosis (IgG4PA/RPF) 2018, and Proposal of a Revised 2023 Version for IgG4-Related Cardiovascular/Retroperitoneal Disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1390851320453939584","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Immunoglobulin G4-related Disease Accompanied by Peripheral Neuropathy: A Report of Two Cases"}]},{"@id":"https://cir.nii.ac.jp/crid/1521136280933424256","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CLINICAL INVESTIGATION : A prevalence study of IgG4-related ophthalmic disease in Japan"}]},{"@id":"https://cir.nii.ac.jp/crid/1522543656105335424","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinico-epidemiological analysis of 1000 cases of orbital tumors"}]},{"@id":"https://cir.nii.ac.jp/crid/1524232505055413760","@type":"Article","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"CLINICAL INVESTIGATION : Pathological findings of infraorbital nerve enlargement in IgG4-related ophthalmic disease"}]},{"@id":"https://cir.nii.ac.jp/crid/1524232505965520768","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@value":"Clinical features and symptoms of IgG4-related ophthalmic disease : a multicenter study"}]},{"@id":"https://cir.nii.ac.jp/crid/2050588892097084032","@type":"Article","resourceType":"学術雑誌論文(journal article)","relationType":["references"],"jpcoar:relatedTitle":[{"@value":"Proposal for diagnostic criteria for IgG4-related kidney disease"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1007/s10384-014-0352-2"},{"@type":"CIA","@value":"210000165079"},{"@type":"OPENAIRE","@value":"doi_dedup___::e8ba822b90c417ef578771ce4d813c9e"},{"@type":"CROSSREF","@value":"10.1080/14397595.2017.1290911_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.7887/jcns.26.419_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1080/14397595.2020.1859710_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.3390/jcm9113458_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.3390/ijms22084083_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1080/02713683.2022.2103152_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1080/1744666x.2023.2274358_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1186/s13075-024-03391-w_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1007/82_2016_47_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.3109/14397595.2015.1069951_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.5692/clinicalneurol.cn-001342_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.3960/jslrt.20048_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1167/iovs.62.1.15_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1080/14397595.2021.1878623_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1093/rheumatology/keaa783_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1016/j.ajoc.2022.101324_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.3179/jjmu.jjmu.r.218_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.2169/naika.110.962_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1253/circj.cj-24-0026_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1093/mr/roae096_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1080/25785826.2024.2430812_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1007/s00535-017-1420-4_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1016/j.ajoc.2018.01.017_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.7878/jjsogd.35.61_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.3390/jcm9124084_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.3390/jcm9082530_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.2169/naika.110.295_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.3390/ijms222111820_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.7878/jjsogd.43.1_2_93_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1007/s10384-024-01072-4_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1007/s10384-024-01116-9_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1093/mr/road056_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1186/s13075-018-1777-7_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.7248/jjrhi.58.187_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1007/s10384-021-00857-1_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.2169/naika.106.2155_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1111/pin.12932_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.2169/naika.110.1193_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1007/s11604-022-01282-1_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1038/s41598-023-29645-2_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.7878/jjsogd.43.1_2_83_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1007/s10384-024-01157-0_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.0300-17_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1007/s00296-020-04555-y_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.3950/jibiinkoka.120.123_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1136/bmjophth-2019-000295_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.2169/internalmedicine.6461-20_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"},{"@type":"CROSSREF","@value":"10.1007/s10384-021-00847-3_references_DOI_LpNC0Hn2iApxPVp5lmV6ueuxBIN"}]}